|
?:authorAffiliation
|
-
[\'Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, U.K. jamie.hartmann-boyce@phc.ox.ac.uk.\', \'Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, U.K.\', \'Medical Sciences Division, University of Oxford, Oxford, U.K.\', \'Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, U.K.\', \'University of North Carolina School of Medicine, Chapel Hill, NC.\', \'Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy.\', \'Peking University Diabetes Center, Peking University People\'s Hospital, China.\', \'Federation de Diabetologie, Bichat Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.\', \'INSERM, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.\', \'UFR de Médecine, Université de Paris, Paris, France.\', \'Diabetes Research Centre, University of Leicester, Leicester, U.K.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}